Patents by Inventor Bradley R. Teegarden

Bradley R. Teegarden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of ??mediated cell adhesion
    Patent number: 7342012
    Abstract: The present invention relates to a compound of the following formula: or a pharmaceutically acceptable salt thereof. Also disclosed are compositions containing the compound and methods of preparing and using the compounds. The compounds of the invention are useful in treating ?L?2 adhesion mediated conditions in a mammal.
    Type: Grant
    Filed: March 3, 2005
    Date of Patent: March 11, 2008
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Ila Sircar, Paul Furth, Bradley R. Teegarden, Marshall Morningstar, Nicholas Smith, Ronald C. Griffith
  • Inhibitors of ?L?2 mediated cell adhesion
    Patent number: 6897225
    Abstract: The present invention relates to a compound of the following formula: or a pharmaceutically acceptable salt thereof. Also disclosed are compositions containing the compound and methods of preparing and using the compounds. The compounds of the invention are useful in treating ?L?2 adhesion mediated conditions in a mammal.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: May 24, 2005
    Assignee: Tanabe Seiyaku Co., Ltd.
    Inventors: Ila Sircar, Marshall Morningstar, Paul Furth, Nicholas Smith, Bradley R. Teegarden, Ronald C. Griffith
  • Inhibitors of &agr;4&bgr;1 mediated cell adhesion
    Patent number: 6596752
    Abstract: The present invention relates to small molecules according to the formula [I]: which are potent inhibitors of &agr;4&bgr;1 mediated adhesion to either VCAM or CS-1 and which can be used for treating or preventing &agr;4&bgr;1 adhesion mediated conditions in a mammal such as a human.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: July 22, 2003
    Assignees: Tanabe Seiyaku Co., Ltd., Pharmacia & Upjohn Company
    Inventors: Thomas J. Lobl, Bradley R. Teegarden, Alexander Polinsky, Gilbert M. Rishton, Masafumi Yamagishi, Steven Tanis, Jed F. Fisher, Edward W. Thomas, Robert A. Chrusciel
  • Inhibitors of alpha 4beta1 mediated cell adhesion
    Publication number: 20030130349
    Abstract: The present invention relates to small molecules according to the formula [I]: 1
    Type: Application
    Filed: July 12, 2002
    Publication date: July 10, 2003
    Applicant: Tanabe Seiyaku Co., Ltd.
    Inventors: Thomas J. Lobl, Bradley R. Teegarden, Alexander Polinsky, Gilbert M. Rishton, Masafumi Yamagishi, Steven Tanis, Jed F. Fisher, Edward W. Thomas, Robert A. Chrusciel
  • Inhibitors of &agr;4&bgr;1 mediated cell adhesion
    Patent number: 6482849
    Abstract: The present invention relates to small molecules according to the formula [I]: which are potent inhibitors of &agr;4&bgr;1 mediated adhesion to either VCAM or CS-1 and which can be used for treating or preventing &agr;4&bgr;1 adhesion mediated conditions in a mammal such as a human.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: November 19, 2002
    Assignees: Tanabe Seiyaku Co., Ltd., Pharmacia & Upjohn Company
    Inventors: Thomas J. Lobl, Bradley R. Teegarden, Alexander Polinsky, Gilbert M. Rishton, Masafumi Yamagishi, Steven Tanis, Jed F. Fisher, Edward W. Thomas, Robert A. Chrusciel